These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 318795)

  • 1. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction.
    Bussmann WD; Löhner J; Kaltenbach M
    Am J Cardiol; 1977 Jan; 39(1):91-6. PubMed ID: 318796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA; Russell RO; Moraski RE; Rackley CE
    Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
    Mikulic E; Franciosa JA; Cohn JN
    Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure.
    Figueras J; Taylor WR; Ogawa T; Forrester JS; Singh BN; Swan HJ
    Br Heart J; 1979 Mar; 41(3):317-24. PubMed ID: 371647
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.
    Franciosa JA; Mikulic E; Cohn JN; Jose E; Fabie A
    Circulation; 1974 Nov; 50(5):1020-4. PubMed ID: 4609633
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction.
    Cantelli I; Pavesi PC; Naccarella F; Bracchetti D
    Int J Cardiol; 1981; 1(2):151-63. PubMed ID: 7338418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.
    Stephens JD; Banim SO; Spurrell RA
    Br Heart J; 1980 Feb; 43(2):220-5. PubMed ID: 7362716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease.
    Stephens J; Camm J; Spurrell R
    Br Heart J; 1978 Aug; 40(8):832-7. PubMed ID: 687484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of sublingual isosorbide dinitrate on hemodynamics in coronary patients with and without congestive heart failure (author's transl)].
    Wolf R; Beck OA; Habel F; Hochrein H
    Z Kardiol; 1977 Aug; 66(8):459-64. PubMed ID: 899150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
    Packer M; Medina N; Yushak M; Lee WH
    Am Heart J; 1985 Jun; 109(6):1293-9. PubMed ID: 3890506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M; Lee WH
    Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.
    Willis WH; Russell RO; Mantle JA; Ratshin RA; Rackley CE
    Chest; 1976 Jan; 69(1):15-22. PubMed ID: 811427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to isosorbide dinitrate in patients with severe chronic heart failure: incidence and attempt at hemodynamic prediction.
    Kulick D; Roth A; McIntosh N; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1988 Oct; 12(4):1023-8. PubMed ID: 3417975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual isosorbide dinitrate in severe congestive heart failure.
    Markiewicz W; Rochman J; Peled B
    Cardiology; 1981; 67(3):172-9. PubMed ID: 7273045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.